A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
Clinical trial NCT02790125 · COMPLETED
Trial details
- NCT number
- NCT02790125
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-28
- Primary completion
- 2017-11-07
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.